BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33815056)

  • 1. Targeted Quantification of Detergent-Insoluble RNA-Binding Proteins in Human Brain Reveals Stage and Disease Specific Co-aggregation in Alzheimer's Disease.
    Guo Q; Dammer EB; Zhou M; Kundinger SR; Gearing M; Lah JJ; Levey AI; Shulman JM; Seyfried NT
    Front Mol Neurosci; 2021; 14():623659. PubMed ID: 33815056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the detergent-insoluble brain proteome linked to amyloid and tau in Alzheimer's Disease progression.
    Hales CM; Dammer EB; Deng Q; Duong DM; Gearing M; Troncoso JC; Thambisetty M; Lah JJ; Shulman JM; Levey AI; Seyfried NT
    Proteomics; 2016 Dec; 16(23):3042-3053. PubMed ID: 27718298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.
    Bishof I; Dammer EB; Duong DM; Kundinger SR; Gearing M; Lah JJ; Levey AI; Seyfried NT
    J Biol Chem; 2018 Jul; 293(28):11047-11066. PubMed ID: 29802200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting Detergent-Insoluble Proteome in Alzheimer's Disease by TMTc-Corrected Quantitative Mass Spectrometry.
    Zaman M; Fu Y; Chen PC; Sun H; Yang S; Wu Z; Wang Z; Poudel S; Serrano GE; Beach TG; Li L; Wang X; Peng J
    Mol Cell Proteomics; 2023 Aug; 22(8):100608. PubMed ID: 37356496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep proteomic network analysis of Alzheimer's disease brain reveals alterations in RNA binding proteins and RNA splicing associated with disease.
    Johnson ECB; Dammer EB; Duong DM; Yin L; Thambisetty M; Troncoso JC; Lah JJ; Levey AI; Seyfried NT
    Mol Neurodegener; 2018 Oct; 13(1):52. PubMed ID: 30286791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggregation properties of the small nuclear ribonucleoprotein U1-70K in Alzheimer disease.
    Diner I; Hales CM; Bishof I; Rabenold L; Duong DM; Yi H; Laur O; Gearing M; Troncoso J; Thambisetty M; Lah JJ; Levey AI; Seyfried NT
    J Biol Chem; 2014 Dec; 289(51):35296-313. PubMed ID: 25355317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enrichment of Detergent-insoluble Protein Aggregates from Human Postmortem Brain.
    Diner I; Nguyen T; Seyfried NT
    J Vis Exp; 2017 Oct; (128):. PubMed ID: 29155708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease.
    Bai B; Hales CM; Chen PC; Gozal Y; Dammer EB; Fritz JJ; Wang X; Xia Q; Duong DM; Street C; Cantero G; Cheng D; Jones DR; Wu Z; Li Y; Diner I; Heilman CJ; Rees HD; Wu H; Lin L; Szulwach KE; Gearing M; Mufson EJ; Bennett DA; Montine TJ; Seyfried NT; Wingo TS; Sun YE; Jin P; Hanfelt J; Willcock DM; Levey A; Lah JJ; Peng J
    Proc Natl Acad Sci U S A; 2013 Oct; 110(41):16562-7. PubMed ID: 24023061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse proteins aggregate in mild cognitive impairment and Alzheimer's disease brain.
    Kepchia D; Huang L; Dargusch R; Rissman RA; Shokhirev MN; Fischer W; Schubert D
    Alzheimers Res Ther; 2020 Jun; 12(1):75. PubMed ID: 32560738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls.
    Ayyadevara S; Balasubramaniam M; Parcon PA; Barger SW; Griffin WS; Alla R; Tackett AJ; Mackintosh SG; Petricoin E; Zhou W; Shmookler Reis RJ
    Aging Cell; 2016 Oct; 15(5):924-39. PubMed ID: 27448508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive transcript-level analysis reveals transcriptional reprogramming during the progression of Alzheimer's disease.
    Wu H; Wang J; Hu X; Zhuang C; Zhou J; Wu P; Li S; Zhao RC
    Front Aging Neurosci; 2023; 15():1191680. PubMed ID: 37396652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic determination of widespread detergent-insolubility including Abeta but not tau early in the pathogenesis of Alzheimer's disease.
    Woltjer RL; Cimino PJ; Boutté AM; Schantz AM; Montine KS; Larson EB; Bird T; Quinn JF; Zhang J; Montine TJ
    FASEB J; 2005 Nov; 19(13):1923-5. PubMed ID: 16129700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network Analysis of a Membrane-Enriched Brain Proteome across Stages of Alzheimer's Disease.
    Higginbotham L; Dammer EB; Duong DM; Modeste E; Montine TJ; Lah JJ; Levey AI; Seyfried NT
    Proteomes; 2019 Aug; 7(3):. PubMed ID: 31461916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-Dependent Changes in the Sarkosyl-Insoluble Proteome of APPSWE/PS1ΔE9 Transgenic Mice Implicate Dysfunctional Mitochondria in the Pathogenesis of Alzheimer's Disease.
    Thygesen C; Metaxas A; Larsen MR; Finsen B
    J Alzheimers Dis; 2018; 64(4):1247-1259. PubMed ID: 29991132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease.
    Delacourte A; Sergeant N; Champain D; Wattez A; Maurage CA; Lebert F; Pasquier F; David JP
    Neurology; 2002 Aug; 59(3):398-407. PubMed ID: 12177374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
    Thal DR; Walter J; Saido TC; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):167-82. PubMed ID: 25534025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep Profiling of the Aggregated Proteome in Alzheimer's Disease: From Pathology to Disease Mechanisms.
    Lutz BM; Peng J
    Proteomes; 2018 Nov; 6(4):. PubMed ID: 30424485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau Interacting Proteins: Gaining Insight into the Roles of Tau in Health and Disease.
    Stancu IC; Ferraiolo M; Terwel D; Dewachter I
    Adv Exp Med Biol; 2019; 1184():145-166. PubMed ID: 32096036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model.
    Herline K; Prelli F; Mehta P; MacMurray C; Goñi F; Wisniewski T
    Alzheimers Res Ther; 2018 Jun; 10(1):54. PubMed ID: 29914551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.